Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

BANK OF NOVA SCOTIA (BNS)

  • SEC News
  • Aug. 28, 2026, 13:52 UTC
  • 2
  • 0 comments

New Form 424B2 - BANK OF NOVA SCOTIA <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001839882-26-042217 <b>Size:</b> 476 KB

Comment Full text

MERCK & CO., INC. (MRK)

  • Business News
  • Aug. 28, 2026, 13:52 UTC
  • 5
  • 1 comments

Clinical trial NCT05298423 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-08-19 → 2026-06-15 3. enrollment: 611 → 610 participants

Market reaction Comment Full text

TAKEDA PHARMACEUTICAL CO LTD (TAK)

  • Business News
  • Aug. 28, 2026, 13:52 UTC
  • 6
  • 1 comments

Clinical trial NCT07429942: start date: 2026-08-31 → 2026-09-10.

Market reaction Comment Full text

BRISTOL MYERS SQUIBB CO (BMY)

  • Business News
  • Aug. 28, 2026, 13:52 UTC
  • 6
  • 1 comments

Clinical trial NCT04090710 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-31 → 2026-06-30 3. primary completion date: 2026-06-30 → 2026-04-23

Market reaction Comment Full text

JOHNSON & JOHNSON (JNJ)

  • Business News
  • Aug. 28, 2026, 13:52 UTC
  • 4
  • 1 comments

Clinical trial NCT06785012: status: ACTIVE_NOT_RECRUITING → COMPLETED.

Market reaction Comment Full text

JOHNSON & JOHNSON (JNJ)

  • Business News
  • Aug. 28, 2026, 13:52 UTC
  • 3
  • 1 comments

Clinical trial NCT04929210: primary completion date: 2026-08-04 → 2027-04-01.

Market reaction Comment Full text

JOHNSON & JOHNSON (JNJ)

  • Business News
  • Aug. 28, 2026, 13:52 UTC
  • 3
  • 1 comments

Clinical trial NCT07665450: start date: 2026-09-14 → 2026-09-22.

Market reaction Comment Full text

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (TSOI)

  • Business News
  • Aug. 28, 2026, 13:52 UTC
  • 7
  • 1 comments

Clinical trial NCT07089043 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment type: ESTIMATED → ACTUAL

Market reaction Comment Full text

SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD./ADR

  • Business News
  • Aug. 28, 2026, 13:52 UTC
  • 5
  • 1 comments

Clinical trial NCT05445908 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-09-01 → 2026-07-31 3. primary completion date: 2027-09-01 → 2026-07-31 4. enrollment: 175 → 184 participants 5. enrollment type: ESTIMATED → ACTUAL

Market reaction Comment Full text

JOHNSON & JOHNSON (JNJ)

  • Business News
  • Aug. 28, 2026, 13:52 UTC
  • 4
  • 1 comments

Clinical trial NCT05201781: completion date: 2042-06-01 → 2041-06-28.

Market reaction Comment Full text

BRISTOL-MYERS SQUIBB CO.

  • Business News
  • Aug. 28, 2026, 13:52 UTC
  • 7
  • 1 comments

Clinical trial NCT02270814 updates: 1. completion date: 2026-06-30 → 2026-09-30 2. primary completion date: 2026-06-30 → 2026-09-30

Market reaction Comment Full text

JOHNSON & JOHNSON (JNJ)

  • Business News
  • Aug. 28, 2026, 13:52 UTC
  • 5
  • 1 comments

Clinical trial NCT07520747 updates: 1. completion date: 2026-07-31 → 2026-08-31 2. primary completion date: 2026-07-31 → 2026-08-31

Market reaction Comment Full text

NURIX THERAPEUTICS, INC. (NRIX)

  • Business News
  • Aug. 28, 2026, 13:52 UTC
  • 6
  • 1 comments

Clinical trial NCT07520006 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-08-01

Market reaction Comment Full text

JOHNSON & JOHNSON (JNJ)

  • Business News
  • Aug. 28, 2026, 13:52 UTC
  • 5
  • 1 comments

Clinical trial NCT07788521: start date: 2026-08-25 → 2026-08-28.

Market reaction Comment Full text

JOHNSON & JOHNSON (JNJ)

  • Business News
  • Aug. 28, 2026, 13:52 UTC
  • 6
  • 1 comments

Clinical trial NCT06618001 updates: 1. completion date: 2028-01-12 → 2026-11-16 2. primary completion date: 2027-07-15 → 2026-11-16

Market reaction Comment Full text
  • Previous
  • 1548
  • 1549
  • 1550
  • 1551
  • 1552
  • Next

Search

News categories

  • Technical Exchange News(14775)
  • Event(6229)
  • SEC News(398991)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(243074)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin